Open AccessS1342 Efficacy of H. pylori Eradication by Low-Dose Rifabutin Triple Therapy (RHB-105) Is Unaffected by BMI: Post-hoc Analysis From Two Phase 3 Trials
Author(s) -
Kely L. Sheldon,
Steven F. Moss,
Mohd Amer Al Samman,
Elliot Offman,
Raymond M. Panas,
June Almenoff
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000707416.27079.6a
Subject(s) - medicine , rifabutin , clarithromycin , amoxicillin , omeprazole , population , post hoc analysis , helicobacter pylori , gastroenterology , breath test , intention to treat analysis , clinical trial , antibiotics , microbiology and biotechnology , environmental health , biology